TRIBE_2: TRIBE, figure 2

TRIBE_2R Documentation

TRIBE, figure 2

Description

Kaplan-Meier digitized data from TRIBE, figure 2 (PMID 26338525). A reported sample size of 508 for a primary endpoint of PFS in colorectal cancer.

Usage

TRIBE_2

Format

A data frame of 508 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (folfiri_bev, folfoxiri_bev)

Source

Cremolini C, Loupakis F, Antoniotti C, et al. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. Lancet Oncol 2015; 16: 1306–15.

Examples

summary(TRIBE_2)

kmplot(TRIBE_2)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.